A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

NCT06637631 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: SAR441566
DRUG: SAR441566 matching Placebo

Sponsor

Sanofi